Inventor · disambiguated record
Andreas Kungl
Also filed as: KUNGL ANDREAS · KUNGL ANDREAS J
5 granted patents·11 pending applications·26 citations·filing 2006–2020
74Inventor score
Top patents by PatentIndex Score
16 records- 0187US7585937B2GAG binding proteinsPROTAFFIN BIOTECHNOLOGIE AG·Filed 2006·Granted Sep 8, 2009·23 cites·16 claims
- 0275US7807413B2GAG binding proteinPROTAFFIN BIOTECHNOLOGIE AG·Filed 2008·Granted Oct 5, 2010·3 cites·16 claims
- 0360US2011144305A1Gag binding proteinPROTAFFIN BIOTECHNOLOGIE AG·Filed 2009·Application pending·0 cites
- 0455US10703790B2Glycosaminoglycan-antagonising fusion proteinsANTAGONIS BIOTHERAPEUTICS GMBH·Filed 2018·Granted Jul 7, 2020·0 cites·2 claims
- 0555US2010298203A1Sdf-i-based glycosaminoglycan antagonists and methods of using samePROTAFFIN BIOTECHNOLOGIE AG·Filed 2008·Application pending·0 cites
- 0652US2011229433A1Use of modified interleukin-8 proteins for treating reperfusion injury or transplant rejectionPROTAFFIN BIOTECHNOLOGIE AG·Filed 2007·Application pending·0 cites
- 0748US8337825B2Glycosaminoglycan-antagonising MCP-1 mutantsKUNGL ANDREAS·Filed 2008·Granted Dec 25, 2012·0 cites·15 claims
- 0847US2010331237A1Gag binding proteinsPROTAFFIN BIOTECHNOLOGIE AG·Filed 2010·Application pending·0 cites
- 0946US10047133B2Glycosaminoglycan-antagonising fusion proteins and methods of using sameANTAGONIS BIOTHERAPEUTICS GMBH·Filed 2015·Granted Aug 14, 2018·0 cites·10 claims
- 1044US2022281934A1T-cell mobilizing cxcl10 mutant with increased glycosaminoglycan binding affinityANTAGONIS BIOTHERAPEUTICS GMBH·Filed 2020·Application pending·0 cites
- 1142US2010035294A1System to assess the biological activity of chemoattractantsPROTAFFIN BIOTECHNOLOGIE AG·Filed 2007·Application pending·0 cites
- 1240US2013150303A1Glycosaminoglycan-antagonising mcp-1 mutants and methods of using samePROTAFFIN BIOTECHNOLOGIE AG·Filed 2012·Application pending·0 cites
- 1338US2012052043A1Chemokine-Chaperone Fusion ProteinsKUNGL ANDREAS·Filed 2007·Application pending·0 cites
- 1431US2014073557A1Fgfri-based antagonists with improved glycosaminoglycan affinity and methods of using sameKUNGL ANDREAS·Filed 2012·Application pending·0 cites
- 1524US2012046218A1Glycosaminoglycan-antagonising mcp-i mutants and methods of using sameKUNGL ANDREAS·Filed 2010·Application pending·0 cites
- 1619US2012288474A1Composition for treatment of cxcl8-mediated lung inflammationKUNGL ANDREAS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andreas Kungl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →